Brain immune system is key to recovery from motor neuron degeneration

February 20, 2018 by Karen Kreeger, Perelman School of Medicine at the University of Pennsylvania
Microglia (red) surrounding a motor neuron in the spinal cord of an engineered mouse and actively clearing human TDP-43 (green) following transgene suppression. Scale= 100 μm. Credit: Virginia M-Y. Lee, PhD and Krista J. Spiller, PhD, Perelman School of Medicine at the University of Pennsylvania

The selective demise of motor neurons is the hallmark of Lou Gehrig's disease, also known as amyotrophic lateral sclerosis (ALS). Yet neurologists have suspected there are other types of brain cells involved in the progression of this disorder—perhaps protection from it, which could light the way to treatment methods for the incurable disease. To get to the bottom of this question, researchers in the Perelman School of Medicine at the University of Pennsylvania engineered mice in which the damage caused by a mutant human TDP-43 protein could be reversed by one type of brain immune cell. TDP-43 is a protein that misfolds and accumulates in the motor areas of the brains of ALS patients.

First author Krista J. Spiller, Ph.D., a postdoctoral fellow, and senior author Virginia M-Y. Lee, Ph.D., director of the Center for Neurodegenerative Disease Research and a professor of Pathology and Laboratory Medicine, published their findings this week in Nature Neuroscience.

They found that microglia, the first and primary immune response in the brain and spinal cord, are essential for dealing with TDP-43-associated neuron death. This study is the first to demonstrate how healthy microglia respond to pathological TDP-43 in a living animal.

"The prevailing view in the field has been that immune system inflammation contributes to the death of neurons in ALS, but this study shows the opposite—that microglia are actually critical for neuronal survival," Lee said.

The number of microglia cells remained stable in with ALS symptoms. However, after the researchers chemically suppressed expression of pathological human TDP-43 in the mice, microglia dramatically proliferated and changed their shape and what genes they expressed.

The researchers were perplexed as to why the microglia did not react automatically to the presence of mutant TDP-43 and how subduing its expression incited microglia to react. "This is still a mystery, but one that we'd very much like to figure out in future studies," Spiller said.

The normally branched microglia retracted their extensions and expanded the size of their main cell bodies. (This rapid change in shape is fairly unique to microglia in the central nervous system, although macrophages, microglia's immune-system counterpart in peripheral parts of the body, are similarly dynamic in their shape shifting.)

The now abundant, remade microglia multiplied by 70 percent after one week and selectively cleared accumulated human TDP-43 from . Microglia surround TDP-43-filled neurons and turned on genes to make proteins that help them attach to the sick cells and induce a process called phagocytosis that envelops the mutant proteins for disposal. After the mop up, mice stopped exhibiting motor dysfunction symptoms such as leg clasping and tremors, and they regained their ability to walk and gain weight.

Conversely, TDP-43 was not fully cleared in mice with no microglia. When proliferation of microglia was blocked, the mice failed to regain full muscle function, revealing how important microglia are for cleaning up clumps of misfolded proteins.

"The way reactive microglia protect neurons points us towards new ideas for ALS therapies," Spiller said. "For example, we want to know if we can encourage the expansion of in early-stage ALS patients to save their motor ."

Explore further: New model may provide insights on neurocognitive disorders caused by HIV

More information: Microglia-mediated recovery from ALS-relevant motor neuron degeneration in a mouse model of TDP-43 proteinopathy, Nature Neuroscience (2018). nature.com/articles/doi:10.1038/s41593-018-0083-7

Related Stories

New model may provide insights on neurocognitive disorders caused by HIV

November 8, 2017
HIV infects certain cells in the brain called microglia, and infected microglia release toxic and inflammatory molecules that can impair or kill surrounding neurons. Researchers have been limited in their ability to study ...

Overactive scavenger cells may cause neurodegeneration in Alzheimer's

June 30, 2017
For the first time, researchers from the University of Zurich demonstrate a surprising effect of microglia, the scavenger cells of the brain: If these cells lack the TDP-43 protein, they not only remove Alzheimer's plaques, ...

Neuroscientists identify genetic changes in microglia in a mouse model of neurodegeneration and Alzheimer's disease

October 13, 2017
Microglia, immune cells that act as the central nervous system's damage sensors, have recently been implicated in Alzheimer's disease.

Researchers discover role of microglia during early progression of Alzheimer's disease

October 5, 2015
For the first time, researchers have determined how toxic tau fibrils spread by the help of brain immune cells called microglia during the early stages of Alzheimer's disease (AD). The discovery of this new pathway may lead ...

Team announces robust, high-throughput protocol for deriving microglia from human stem cells

May 18, 2017
Scientists from the New York Stem Cell Foundation (NYSCF) Research Institute have developed a robust, efficient method for deriving microglia, the immune cells of the brain, from human stem cells. Microglia are increasingly ...

Alzheimer's risk linked to energy shortage in brain's immune cells

August 14, 2017
People with specific mutations in the gene TREM2 are three times more likely to develop Alzheimer's disease than those who carry more common variants of the gene. But until now, scientists had no explanation for the link.

Recommended for you

Dopamine's yin-yang personality: It's an upper and a downer

December 10, 2018
For decades, psychologists have viewed the neurotransmitter dopamine as a double-edged sword: released in the brain as a reward to train us to seek out pleasurable experiences, but also a "drug" the constant pursuit of which ...

Brainwaves suppress obvious ideas to help us think more creatively

December 10, 2018
The human brain needs to suppress obvious ideas in order to reach the most creative ones, according to scientists at Queen Mary University of London and Goldsmiths, University of London.

Regrowing damaged nerves hinges on shutting down key genes

December 10, 2018
Neurons in the brain and spinal cord don't grow back after injury, unlike those in the rest of the body. Cut your finger, and you'll probably be back to using it in days or weeks; slice through your spinal cord, and you likely ...

Editing consciousness: How bereaved people control their thoughts without knowing it

December 10, 2018
People who are grieving a major loss, such as the death of a spouse or a child, use different coping mechanisms to carry on with their lives. Psychologists have been able to track different approaches, which can reflect different ...

Ezogabine treatment shown to reduce motor neuron excitability in ALS patients

December 10, 2018
Brian Wainger, MD, Ph.D., of the Healey Center for ALS at Massachusetts General Hospital (MGH) presented initial, top-level results of a recently completed phase 2 clinical trial of ezogabine (also called retigabine) on December ...

Team seeks to create genetic map of worm's nervous system

December 10, 2018
How do you build a brain? What "rules" govern where neurons end up, how they connect to each other, and which functions they perform?

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.